Featured Coverage
FDA grants 'breakthrough' status to generative AI chatbot for surgical patients
"The FDA has granted breakthrough device designation to RecovryAI's generative AI chatbot — marking the first time the agency has given such status to a patient-facing large language model in a clinical care setting."Read article →
In the Press
FDA Offers Clues To AI Regulation With RecovryAI Designation
The agency's decision signals a framework for how generative AI in patient-facing clinical contexts may be evaluated under existing device law.
Read →
"Health care innovation will not scale without trust"
CEO Scott Walchek on why regulatory validation is the prerequisite for health care AI adoption at scale.
Read →
RecovryAI Wins FDA Breakthrough Nod for Patient-Facing Clinical AI
The designation applies to RecovryAI's Virtual Care Assistants supporting post-operative recovery in total joint arthroplasty patients.
Read →
Also covered by
Community Reaction
The conversation on LinkedIn
CS
"This is the way. Patient facing AI in medicine will be much more impactful than clinician tools."
ZC
"The governance frameworks being written around RecovryAI will set the standard for every patient-facing AI that follows."
LB
"Fairly major news — the first chatbot given a 'breakthrough' designation by the US FDA."
EH
"FDA has granted 'breakthrough designation' to an LLM-based AI chatbot for a very specific use case."
AA
"The FDA just gave generative AI a foothold in post-surgical care."